Abstract:Objectives To assess diagnostic accuracy of 2D ultrasound at 11‐14 weeks gestation as a screening test for individual fetal anomalies and identify screening factors impacting detection. Methods Systematic review and meta‐analysis, developed and registered with PROSPERO (CRD42018111781). MEDLINE, EMBASE, Web of Science Core Collection and The Cochrane Library) were searched for studies evaluating the diagnostic accuracy of screening for 16 pre‐specified, non‐cardiac, congenital anomalies considered to be of interest to the early anomaly scan. We included prospective and retrospective studies from any healthcare setting and low risk, mixed risk and unselected populations. The reference standard was the detection of an anomaly on postnatal or post‐mortem examination. Data were extracted to populate 2 x 2 tables and meta‐analysis (random‐effects model) undertaken to determine the diagnostic accuracy of screening for the pre‐specified anomalies (individually and as a composite). Secondary analyses were performed to determine the impact of (1) imaging protocol (2) ultrasound modality (3) publication year and (4) index of sonographer suspicion at time of scan. Post‐hoc secondary analysis was conducted to assess performance for studies from 2010. Risk of bias and quality assessment was undertaken for included studies using the Quality Assessment of Diagnostic Accuracy Studies (QUADAS‐2). Results From 5684 citations, 202 papers were identified as eligible and reviewed, resulting in the inclusion of 526,322 fetuses (52 studies) of which 2,399 were affected by one or more of the 16 anomalies. Individual anomalies were not equally amenable to detection on first trimester ultrasound ranging from high (>80%) detection rates for severe conditions including acrania (98%), gastroschisis (96%) and exomphalos (95%) and holoprosencephaly (88%); they were lower for open spina bifida (69%), lower urinary tract obstruction (66%) lethal skeletal dysplasias (57%) and limb reduction defects (50%) and below 50% for facial clefts (43%), polydactyly (40%) and congenital diaphragmatic hernia (38). Conditions with low ( 99% for all anomalies. Secondary analysis showed improvement of detection with publication year, and that the use of imaging protocols had a statistically significant impact on screening performance (p<0.0001). Conclusions Accurate detection of congenital anomalies using first trimester ultrasound is feasible. In this study we have determined screening characteristics for individual anomalies and have shown that detection rates and false positive rates are dependent on the type of anomaly. The use of a standardised protocol allows diagnostic performance to be maximised, and this particularly enhances screening performance for the detection of spina bifida, facial clefts and limb reduction defects. Highlighting the types of anomalies amenable to diagnosis and determining favourable screening test factors can support the development of first‐trimester anomaly screening programs. This article is protected by copyright. All rights reserved.

Ultrasonographic diagnosis of trisomy 18: is it practical in the early second trimester?

Predictive Significance of Risk Value in Prenatal Screening for Fetal Trisomy 18

Noninvasive Prenatal Testing of Trisomies 21 and 18 by Massively Parallel Sequencing of Maternal Plasma DNA in Twin Pregnancies.

Sonographic features of trisomy 18 at midpregnancy

Clinical application of noninvasive prenatal testing for the detection of trisomies 21, 18, and 13: a hospital experience.

Analysis of Sonographic Features of Trisomy 18

Fetal choroid plexus cysts and trisomy 18: assessment of risk based on ultrasound findings and maternal age

Prenatal diagnosis in the first trimester of pregnancy

First-Trimester Ultrasound Screening in Routine Obstetric Practice

Ultrasonographically detectable markers of fetal chromosomal abnormalities

Prenatal Diagnosis for Trisomy 18——analysis of 9 Cases

A retrospective evaluation of second-trimester serum screening for fetal trisomy 18: experience of two laboratories

Fetal Heart Rate Patterns and Umbilical Artery Flow Velocity Waveforms in Pregnancies with Trisomy 21

Prenatal diagnosis of mosaic trisomy 18 and maternal uniparental disomy 18 by amniocentesis in a pregnancy associated with cytogenetic discrepancy in various tissues and a favorable fetal outcome

[Study on Several Ultrasound Markers Combined Maternal Serum Biochemical Markers to Screen Fetal Chromosomal Aneuploidy at 11 to 13(+)6 Weeks of Gestation].

Low-level mosaic trisomy 21 at amniocentesis and cordocentesis in the second trimester in a pregnancy associated with positive non-invasive prenatal testing for trisomy 21, perinatal progressive decrease of the trisomy 21 cell line and a favorable fetal outcome

A rare case of trisomy 13 mosaicism with only findings on first-trimester ultrasound single umbilical artery and increased nuchal translucency

Study on the Application of Ultrasonography in the Diagnosis of Fetal Cardiac Structural Abnormalities and the Relationship Between Fetal Cardiac Structural Abnormalities with Chromosome Abnormalities in Early Pregnancy.

Analysis of chromosomal karyotypes in 119 fetal blood cases during the second and third trimesters of gestation

[First-trimester screening for trisomies 18 and 13 with the combined use of the risk algorithms for trisomy 21, 18 and 13]

Detection of non‐cardiac fetal abnormalities by ultrasound at 11–14 weeks: systematic review and meta‐analysis